Australia: Australian Red Cross Lifeblood issued an urgent national appeal on 4 August for 12,000 additional donors after ongoing shortages of type O and A blood. Lifeblood reported that O-positive and O-negative supplies remained low and that A-positive stocks had also fallen. Its national blood-supply page, updated 4 September, continued to classify O-negative as Low, with O-positive and A-positive requiring additional donations.
Wales: On 17 July, the Welsh Blood Service appealed for donors to help fill 13,000 summer appointments after heatwaves caused around 1,400 donation appointments to be cancelled. The service said it aims to maintain at least seven days of stock for every blood group and was particularly encouraging A-positive, O-positive, O-negative and B-negative donors to come forward.
These events are not failures of transfusion medicine. Donor blood remains essential and life-saving. They show a structural constraint: blood must be donated, typed, tested, processed, stored, transported and available in the right group at the right place and time.
BHOC perspective: This is the gap that makes complementary oxygen-delivery technologies strategically relevant. The objective is not to replace donor blood, but to strengthen resilience when compatible blood is unavailable, delayed or logistically constrained, particularly in trauma, prehospital emergency care, postpartum hemorrhage, remote medicine and mass-casualty settings.
Blood-stock levels are dynamic. The figures above are dated system signals from official blood-service reports and should not be interpreted as permanent stock levels. No claim is made here that blood was shipped from Wales to Australia.
